• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢肿瘤体积和总病灶糖酵解对早期肺癌术前分期预后预测的贡献。

Contribution of Metabolic Tumor Volume and Total Lesion Glycolysis to Predict Prognosis in Early-Stage Lung Cancer at Preoperative Staging.

作者信息

Karaman Elanur, Goksel Sibel, Tuluce Kerim

机构信息

Department of Medical Oncology, Recep Tayyip Erdogan University Education and Research Hospital, Rize, Turkey.

Department of Nuclear Medicine, Recep Tayyip Erdogan University Education and Research Hospital, Rize, Turkey.

出版信息

J Coll Physicians Surg Pak. 2022 Jun;32(6):740-745. doi: 10.29271/jcpsp.2022.06.740.

DOI:10.29271/jcpsp.2022.06.740
PMID:35686405
Abstract

OBJECTIVE

To evaluate the effect of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) values of the primary tumor measured by preoperative positron emission tomography/computed tomography (FDG-PET/CT) on survival in patients with operated non-small cell lung cancer (NSCLC).

STUDY DESIGN

Cohort study.

PLACE AND DURATION OF STUDY

Recep Tayyip Erdogan University, Faculty of Medicine, Department of Medical Oncology from January 2017 to June 2020, Turkey.

METHODOLOGY

Patients with operated NSCLC were reviewed retrospectively. Metabolic parameters of FDG-PET/CT such as pathological tumor features, type of operation, MTV/TLG values, and whether they received adjuvant therapy were evaluated. Disease-free survival (DFS) and overall survival (OS) times were calculated.

RESULTS

Most of the 77 patients (96.1%) were male. The mean age is 64±8 years. Lobectomy was performed in 66 (85.7%) patients, and pneumonectomy was performed in 11 (14.3%) patients. The mean tumor diameter was 3.7±2.015cm. Squamous cell carcinoma was detected in 37 patients (48.1%) and adenocarcinoma in 35 patients (45.5%). Thirty-eight patients (49.4%) received adjuvant chemotherapy. SUVmax, MTV, and TLG values of the primary tumor were high in patients under 65 years of age and with a tumor diameter of ≥3cm. DFS was nine months (4.5-18), and OS was 19 months (11-29). The 2-year survival rate was 75.6%. It was observed that patients with adenocarcinoma relapsed more frequently, which negatively affected survival (p=0.023, and p=0.024 respectively). High MTV (p=0.01) and TLG (p=0.015) values were associated with poor prognosis.

CONCLUSION

NSCLC is a heterogeneous disease, and survival is affected by many factors. Our study showed that the subtype of adenocarcinoma and high MTV and TLG values of the primary tumor are poor prognostic factors in operated early-stage lung cancers.

KEY WORDS

Early-stage, Non-small cell lung cancer, MTV, TLG, NSCLC, Survival, FDG-PET/CT.

摘要

目的

评估术前正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)测量的原发性肿瘤代谢肿瘤体积(MTV)和总病变糖酵解(TLG)值对接受手术的非小细胞肺癌(NSCLC)患者生存的影响。

研究设计

队列研究。

研究地点和时间

2017年1月至2020年6月,土耳其雷杰普·塔伊普·埃尔多安大学医学院医学肿瘤学系。

方法

对接受手术的NSCLC患者进行回顾性研究。评估FDG-PET/CT的代谢参数,如病理肿瘤特征、手术类型、MTV/TLG值以及他们是否接受辅助治疗。计算无病生存期(DFS)和总生存期(OS)。

结果

77例患者中的大多数(96.1%)为男性。平均年龄为64±8岁。66例(85.7%)患者行肺叶切除术,11例(14.3%)患者行全肺切除术。平均肿瘤直径为3.7±2.015cm。37例(48.1%)患者检测到鳞状细胞癌,35例(45.5%)患者检测到腺癌。38例(49.4%)患者接受了辅助化疗。65岁以下且肿瘤直径≥3cm的患者原发性肿瘤的SUVmax、MTV和TLG值较高。DFS为9个月(4.5-18),OS为19个月(11-29)。2年生存率为75.6%。观察到腺癌患者复发更频繁,这对生存产生了负面影响(分别为p=0.023和p=0.024)。高MTV(p=0.01)和TLG(p=0.015)值与预后不良相关。

结论

NSCLC是一种异质性疾病,生存受多种因素影响。我们的研究表明,腺癌亚型以及原发性肿瘤的高MTV和TLG值是早期肺癌手术后的不良预后因素。

关键词

早期;非小细胞肺癌;MTV;TLG;NSCLC;生存;FDG-PET/CT

相似文献

1
Contribution of Metabolic Tumor Volume and Total Lesion Glycolysis to Predict Prognosis in Early-Stage Lung Cancer at Preoperative Staging.代谢肿瘤体积和总病灶糖酵解对早期肺癌术前分期预后预测的贡献。
J Coll Physicians Surg Pak. 2022 Jun;32(6):740-745. doi: 10.29271/jcpsp.2022.06.740.
2
Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters.根据非小细胞肺癌的组织学类型,GLUT1 的差异表达及其与体积依赖性参数的关系及其预后意义。
Lung Cancer. 2017 Feb;104:31-37. doi: 10.1016/j.lungcan.2016.12.003. Epub 2016 Dec 15.
3
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
4
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.代谢肿瘤负荷 18F-FDG PET 在非手术治疗的非小细胞肺癌患者中的预后价值。
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):27-38. doi: 10.1007/s00259-011-1934-6. Epub 2011 Sep 23.
5
Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.采用 FDG PET/CT 测量的容积参数在接受立体定向体部放射治疗的 I 期 NSCLC 患者中的应用:预后价值。
Radiology. 2014 Jan;270(1):275-81. doi: 10.1148/radiol.13130652. Epub 2013 Oct 28.
6
FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描代谢肿瘤体积和总病灶糖酵解预测晚期肺腺癌患者的预后。
J Cancer Res Clin Oncol. 2014 Jan;140(1):89-98. doi: 10.1007/s00432-013-1545-7. Epub 2013 Nov 6.
7
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.18F-FDG PET/CT在手术治疗的非小细胞肺癌中的预后价值:一项Meta分析。
PLoS One. 2016 Jan 4;11(1):e0146195. doi: 10.1371/journal.pone.0146195. eCollection 2016.
8
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.治疗前 FDG PET/CT 全身总病变糖酵解对非小细胞肺癌的预后价值。
Radiology. 2012 Aug;264(2):559-66. doi: 10.1148/radiol.12111148. Epub 2012 Jun 12.
9
Combination of circulating tumor cells and 18F-FDG PET/CT for precision diagnosis in patients with non-small cell lung cancer.循环肿瘤细胞与 18F-FDG PET/CT 联合应用于非小细胞肺癌患者的精准诊断。
Cancer Med. 2024 Sep;13(18):e70216. doi: 10.1002/cam4.70216.
10
Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.(18)F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的基于体积的参数可改善手术切除后早期非小细胞肺癌的预后预测。
Ann Surg. 2013 Feb;257(2):364-70. doi: 10.1097/SLA.0b013e318262a6ec.

引用本文的文献

1
Metabolic and multi-model intravoxel incoherent motion parameters based F-FDG PET/MRI for predicting subtypes of inoperable non-small cell lung cancer.基于代谢和多模型体素内不相干运动参数的F-FDG PET/MRI用于预测不可切除非小细胞肺癌的亚型
BMC Cancer. 2025 Feb 21;25(1):322. doi: 10.1186/s12885-025-13543-z.
2
Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.能量代谢作为晚期非小细胞肺癌治疗的核心:预测、预防和个性化医学框架下的全面视角
EPMA J. 2024 Apr 8;15(2):289-319. doi: 10.1007/s13167-024-00357-5. eCollection 2024 Jun.